Evidence map›Paper›PMID 37114456›Full record

SynthesisInternational journal of technology assessment in health care2023

Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review.

Yunxi Zhang, Maria T Peña, Lauren M Fletcher, Lincy Lal, J Michael Swint, Jennifer C Reneker

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in International journal of technology assessment in health care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Yunxi ZhangDepartment of Data Science, John D. Bower School of Population Health, University of Mississippi Medical Center, Jackson, MS39216, USA.ORCID https://orcid.org/0000-0002-2614-5246
Maria T PeñaDepartment of Management, Policy and Community Health, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX78712, USA.
Lauren M FletcherBrown University Library, Brown University, Providence, RI02912, USA.
Lincy LalDepartment of Management, Policy and Community Health, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX78712, USA.
J Michael SwintDepartment of Management, Policy and Community Health, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX78712, USA.
Jennifer C RenekerDepartment of Population Health Science, John D. Bower School of Population Health, University of Mississippi Medical Center, Jackson, MS39216, USA.
The University of Texas Health Science Center · USUniversity of Mississippi Medical Center · USBrown University · USCenter for Clinical Research (United States) · US

Funding

HRSA HHS 2 U66RH31459-04-00
6 · The paper itself

Abstract

backgroundRemote patient monitoring (RPM) has emerged as a viable and valuable care delivery method to improve chronic disease management. In light of the high prevalence and substantial economic burden of cardiovascular disease (CVD), this systematic review examines the cost and cost-effectiveness of using RPM to manage CVD in the United States.

methodsWe systematically searched databases to identify potentially relevant research. Findings were synthesized for cost and cost-effectiveness by economic study type with consideration of study perspective, intervention, clinical outcome, and time horizon. The methodological quality was assessed using the Joanna Briggs Institute Checklist for Economic Evaluations.

resultsThirteen articles with fourteen studies published between 2011 and 2021 were included in the final review. Studies from the provider perspective with a narrow scope of cost components identified higher costs and similar effectiveness for the RPM group relative to the usual care group. However, studies from payer and healthcare sector perspectives indicate better clinical effectiveness of RPM relative to usual care, with two cost-utility analysis studies suggesting that RPM relative to usual care is a cost-effective tool for CVD management even at the conservative $50,000 per Quality-Adjusted Life-Year threshold. Additionally, all model-based studies revealed that RPM is cost-effective in the long run.

conclusionsFull economic evaluations identified RPM as a potentially cost-effective tool, particularly for long-term CVD management. In addition to the current literature, rigorous economic analysis with a broader perspective is needed in evaluating the value and economic sustainability of RPM.

Indexed as

Cardiovascular DiseasesCost-Benefit AnalysisDelivery of Health CareHumansMonitoring, PhysiologicTreatment OutcomeUnited StatesCardiovascular diseasesCost-effectivenessCostsEconomic evaluationRemote patient monitoringTelehealthTelemedicine

Identifiers

PMID37114456
PMCPMC11574531
OpenAlexW4367320853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.